Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...
Novo’s obesity drug sales nearly doubled outside the U.S. during the quarter as global demand continued to rise.
52mon MSN
Read about Novo Nordisk, Ramsay Health Care and more in the latest Market Talks covering the Health Care sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback